Income Statement Brainlab SE

Stocks

BNLB

DE0005207906

End-of-day quote Deutsche Boerse AG			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-

02-25	Brainlab SE and Precision NeuroMed Announce Strategic Partnership to Standardize and Scale Precision Drug Delivery to the Brain	CI
20/10/25	Marine Shipbuilder TKMS Makes Spectacular Stock Market Debut	DP

c727e.JP3idUQlbNOGMpunHIIVRNTJLcp52cLW9zGoFpcvqMU.UtCAFjQXBZDyXu7LcdR7G46EGfIpg_vur1PnY_NK0ugUj4lFLGkhhL5nyg

Published financial data: BRAINLAB SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Revenues	359M	364M	429M	470M
Total Revenues	359M	364M	429M	470M
Cost of Goods Sold, Total	144M	148M	161M	176M
Gross Profit	215M	216M	268M	294M
Selling General & Admin Expenses, Total	146M	165M	184M	193M
R&D Expenses	53.68M	61.11M	75.03M	86.1M
Other Operating Expenses	-22.01M	-14.96M	-14.55M	-9.2M
Other Operating Expenses, Total	178M	211M	245M	270M
Operating Income	37.22M	5.02M	23.34M	23.53M
Interest Expense, Total	-3.67M	-5.31M	-6.37M	-10.56M
Interest And Investment Income	96K	1.32M	557K	703K
Net Interest Expenses	-3.58M	-3.99M	-5.81M	-9.86M
Income (Loss) On Equity Invest.	160K	5.21M	-307K	-1.69M
Currency Exchange Gains (Loss)	122K	-2.33M	-5.1M	-8.3M
Other Non Operating Income (Expenses)	-	-	-2.9M	-1.95M
EBT, Excl. Unusual Items	33.92M	3.91M	9.23M	1.73M
Impairment of Goodwill	-	-	-5.13M	-10.73M
Other Unusual Items	306K	235K	-	3.06M
EBT, Incl. Unusual Items	34.23M	4.14M	4.1M	-5.93M
Income Tax Expense	11.88M	851K	14.73M	7.5M
Earnings From Continuing Operations	22.35M	3.29M	-10.64M	-13.43M
Net Income to Company	22.35M	3.29M	-10.64M	-13.43M
Minority Interest	-	-98K	-87K	-625K
Net Income - (IS)	22.35M	3.2M	-10.72M	-14.06M
Net Income to Common Incl Extra Items	22.35M	3.2M	-10.72M	-14.06M
Net Income to Common Excl. Extra Items	22.35M	3.2M	-10.72M	-14.06M
Per Share Items
Net EPS - Basic	1.18	0.17	-0.57	-0.75
Basic EPS - Continuing Operations	1.18	0.17	-0.57	-0.75
Basic Weighted Average Shares Outstanding	18.86M	18.86M	18.86M	18.86M
Net EPS - Diluted	1.18	0.17	-0.57	-0.75
Diluted EPS - Continuing Operations	1.18	0.17	-0.57	-0.75
Diluted Weighted Average Shares Outstanding	18.86M	18.86M	18.86M	18.86M
Normalized Basic EPS	1.12	0.12	0.3	0.02
Normalized Diluted EPS	1.12	0.12	0.3	0.02
Dividend Per Share	0.27	0.27	-	-
Payout Ratio	18.57	159.36	-	-
Supplemental Items
EBITDA	47.86M	17.2M	36.98M	36.49M
EBITA	40.32M	8.18M	27.26M	26.65M
EBIT	37.22M	5.02M	23.34M	23.53M
EBITDAR	48.34M	17.33M	37.21M	36.69M
Effective Tax Rate - (Ratio)	34.7	20.53	359.58	-126.39
Normalized Net Income	21.2M	2.35M	5.68M	458K
Interest on Long-Term Debt	794K	798K	779K	669K
Non-Cash Pension Expense	0	0	0	-2K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	53.74M	62.77M	75.03M	86.1M
Net Rental Expense, Total	480K	124K	231K	205K
Imputed Operating Lease Interest Expense	-	32.08K	55.5K	65.75K
Imputed Operating Lease Depreciation	-	91.92K	175K	139K

Fiscal Period: September	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Assets
Cash And Equivalents	85.93M	66.74M	86.34M	78.99M
Short Term Investments	3.18M	-	-	-
Total Cash And Short Term Investments	89.11M	66.74M	86.34M	78.99M
Accounts Receivable, Total	96.39M	107M	125M	145M
Other Receivables	5.22M	7.2M	7.25M	11.58M
Total Receivables	102M	114M	133M	157M
Inventory	48.83M	59.74M	64.83M	68.26M
Prepaid Expenses	8.94M	12.33M	13.66M	11.63M
Other Current Assets, Total	630K	1.43M	2.65M	4.4M
Total Current Assets	249M	254M	300M	320M
Gross Property Plant And Equipment	138M	154M	151M	152M
Accumulated Depreciation	-45.54M	-55.6M	-60.08M	-66.4M
Net Property Plant And Equipment	92.51M	98.37M	91.07M	85.36M
Long-term Investments	3.98M	3.06M	4.42M	13.98M
Goodwill	75.71M	102M	91.3M	67.67M
Other Intangibles, Total	21.97M	43.01M	165M	169M
Accounts Receivable Long-Term	28.76M	39.74M	46.06M	57.72M
Deferred Tax Assets Long-Term	8.95M	15.77M	10.69M	11.75M
Deferred Charges Long-Term	84M	106M	-	-
Other Long-Term Assets, Total	8.74M	5.96M	7.26M	8.12M
Total Assets	574M	668M	716M	733M
Liabilities
Accounts Payable, Total	25.05M	33.26M	32.69M	45.07M
Accrued Expenses, Total	-	-	39.3M	35.87M
Current Portion of Long-Term Debt	45.61M	39.04M	10.03M	16.48M
Current Portion of Leases	10M	11.39M	11.42M	12.37M
Current Income Taxes Payable	7.1M	12.84M	6.75M	6.76M
Unearned Revenue Current, Total	58.96M	69.77M	72.95M	75.58M
Other Current Liabilities	53.18M	67.12M	31.36M	14.83M
Total Current Liabilities	200M	233M	205M	207M
Long-Term Debt	40.38M	72.91M	174M	206M
Long-Term Leases	54.35M	54.86M	50.6M	46.31M
Unearned Revenue Non Current	14.5M	18.15M	17.42M	16.36M
Pension & Other Post Retirement Benefits	-	-	-	4.66M
Deferred Tax Liability Non Current	29.01M	35.69M	42.92M	47.29M
Other Non Current Liabilities	17.42M	22.22M	16.95M	11.34M
Total Liabilities	356M	437M	506M	539M
Common Stock, Total	18.86M	18.86M	18.86M	18.86M
Additional Paid In Capital	32.54M	32.54M	32.54M	-
Retained Earnings	156M	150M	139M	125M
Comprehensive Income and Other	10.65M	26M	16.46M	46.62M
Total Common Equity	218M	228M	207M	191M
Minority Interest	-	3.03M	3.12M	3.76M
Total Equity	218M	231M	210M	194M
Total Liabilities And Equity	574M	668M	716M	733M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	18.86M	18.86M	18.86M	18.86M
ECS Total Common Shares Outstanding	18.86M	18.86M	18.86M	18.86M
Book Value / Share	11.57	12.06	10.97	10.11
Tangible Book Value	121M	82.97M	-49.7M	-45.75M
Tangible Book Value Per Share	6.39	4.4	-2.63	-2.43
Total Debt	150M	178M	246M	281M
Net Debt	61.22M	111M	160M	202M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-440K	-193K	-317K	-397K
Debt Equivalent Oper. Leases	3.84M	992K	1.85M	1.64M
Minority Interest, Total (Incl. Fin. Div)	-	3.03M	3.12M	3.76M
Equity Method Investments, Total	2.6M	-	79K	5.13M
Account Code - Inventory Valuation	-	3	3	3
Inventories - Raw Materials, Total	5.66M	6.72M	8M	7.2M
Inventories - Work In Process, Total	-	1.44M	4.45M	4.12M
Inventories - Finished Goods, Total	43.16M	51.59M	52.38M	56.93M
Land - (BS)	16.98M	21.14M	21.37M	21.16M
Machinery, Total	55.1M	65.96M	67.42M	71.55M
Full Time Employees	-	2.18K	2.27K	2.37K

Fiscal Period: September	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Net Income	22.35M	3.2M	-10.72M	-14.06M
Depreciation & Amortization - CF	18.17M	21.03M	22.6M	23.16M
Amortization of Goodwill and Intangible Assets - (CF)	3.11M	3.16M	3.92M	3.12M
Depreciation & Amortization, Total	21.28M	24.19M	26.52M	26.28M
Amortization of Deferred Charges, Total - (CF)	19.16M	21.27M	30.92M	34.45M
(Gain) Loss From Sale Of Asset	-7.01M	-12.67M	-527K	-3.66M
Asset Writedown & Restructuring Costs	-	-	5.13M	11.05M
(Income) Loss On Equity Investments - (CF)	-160K	-5.21M	307K	1.69M
Other Operating Activities, Total	-4.39M	25K	13.34M	8.88M
Change In Accounts Receivable	-10.22M	-15.88M	-34.2M	-33.22M
Change In Inventories	-11.07M	-3.64M	-6.76M	-3.43M
Change In Accounts Payable	4.35M	4.24M	-1.18M	80K
Change in Unearned Revenues	-387K	9.77M	3.92M	1.37M
Change In Deferred Taxes	97K	5.46M	238K	-
Change in Other Net Operating Assets	3.23M	5.22M	-2.19M	-9.04M
Cash from Operations	37.23M	35.97M	24.81M	20.4M
Capital Expenditure	-9.65M	-8.27M	-8.3M	-7.88M
Sale of Property, Plant, and Equipment	95K	175K	546K	1.41M
Cash Acquisitions	-12.27M	-16.89M	-69K	-
Divestitures	-	-	-	20.08M
Sale (Purchase) of Intangible assets	-33.96M	-42.61M	-53.2M	-50.78M
Investment in Marketable and Equity Securities, Total	3.62M	3.26M	-1.16M	-15.04M
Other Investing Activities, Total	-	-	-1K	-
Cash from Investing	-52.16M	-64.34M	-62.19M	-52.21M
Long-Term Debt Issued, Total	30M	101M	97M	151M
Total Debt Issued	30M	101M	97M	151M
Long-Term Debt Repaid, Total	-18.19M	-91.65M	-37.76M	-126M
Total Debt Repaid	-18.19M	-91.65M	-37.76M	-126M
Common Dividends Paid	-4.15M	-5.09M	-	-
Common & Preferred Stock Dividends Paid	-4.15M	-5.09M	-	-
Cash from Financing	7.66M	4.49M	59.24M	25.68M
Foreign Exchange Rate Adjustments	330K	4.68M	-2.27M	-
Miscellaneous Cash Flow Adjustments	-	-	-	-1.21M
Net Change in Cash	-6.94M	-19.19M	19.6M	-7.35M
Supplemental Items
Cash Interest Paid	2.38M	2.46M	6.03M	7.39M
Cash Income Tax Paid (Refund)	17.76M	2.81M	4.56M	4.29M
Levered Free Cash Flow	-	5.77M	-19.85M	-18.36M
Unlevered Free Cash Flow	-	9.09M	-15.87M	-11.76M
Change In Net Working Capital	-	-11.38M	26.41M	28.53M
Net Debt Issued / Repaid	11.81M	9.59M	59.24M	25.68M

Fiscal Period: September	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Profitability
Return on Assets	-	0.51	2.11	2.03
Return on Total Capital	-	0.81	3.37	3.16
Return On Equity %	-	1.47	-4.83	-6.64
Return on Common Equity	-	1.43	-4.94	-7.07
Margin Analysis
Gross Profit Margin %	59.93	59.35	62.45	62.49
SG&A Margin	40.72	45.3	42.92	41.13
EBITDA Margin %	13.35	4.72	8.62	7.76
EBITA Margin %	11.25	2.25	6.35	5.67
EBIT Margin %	10.38	1.38	5.44	5
Income From Continuing Operations Margin %	6.23	0.9	-2.48	-2.86
Net Income Margin %	6.23	0.88	-2.5	-2.99
Net Avail. For Common Margin %	6.23	0.88	-2.5	-2.99
Normalized Net Income Margin	5.91	0.64	1.32	0.1
Levered Free Cash Flow Margin	-	1.58	-4.62	-3.9
Unlevered Free Cash Flow Margin	-	2.5	-3.7	-2.5
Asset Turnover
Asset Turnover	-	0.59	0.62	0.65
Fixed Assets Turnover	-	3.82	4.53	5.33
Receivables Turnover (Average Receivables)	-	3.59	3.7	3.48
Inventory Turnover (Average Inventory)	-	2.73	2.59	2.65
Short Term Liquidity
Current Ratio	1.25	1.09	1.47	1.55
Quick Ratio	0.95	0.77	1.07	1.14
Operating Cash Flow to Current Liabilities	0.19	0.15	0.12	0.1
Days Sales Outstanding (Average Receivables)	-	101.71	98.66	105.26
Days Outstanding Inventory (Average Inventory)	-	133.79	141.04	138.07
Average Days Payable Outstanding	-	66.92	72.38	93.01
Cash Conversion Cycle (Average Days)	-	168.57	167.32	150.32
Long Term Solvency
Total Debt/Equity	68.89	77.29	117.07	144.59
Total Debt / Total Capital	40.79	43.6	53.93	59.12
LT Debt/Equity	43.41	55.42	106.86	129.75
Long-Term Debt / Total Capital	25.7	31.26	49.23	53.05
Total Liabilities / Total Assets	61.97	65.48	70.68	73.49
EBIT / Interest Expense	10.13	0.95	3.67	2.23
EBITDA / Interest Expense	15.92	5.5	7.83	4.72
(EBITDA - Capex) / Interest Expense	13.3	3.94	6.53	3.97
Total Debt / EBITDA	2.57	6.1	4.93	5.64
Net Debt / EBITDA	1.05	3.82	3.2	4.06
Total Debt / (EBITDA - Capex)	3.08	8.51	5.92	6.7
Net Debt / (EBITDA - Capex)	1.25	5.32	3.84	4.82
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	1.61	17.82	9.56
Gross Profit, 1 Yr. Growth %	-	0.62	23.98	9.64
EBITDA, 1 Yr. Growth %	-	-64.06	437.62	3.19
EBITA, 1 Yr. Growth %	-	-79.72	-1.37K	3.94
EBIT, 1 Yr. Growth %	-	-86.51	-540.29	8.34
Earnings From Cont. Operations, 1 Yr. Growth %	-	-85.26	-422.86	26.32
Net Income, 1 Yr. Growth %	-	-85.7	-435.48	31.12
Normalized Net Income, 1 Yr. Growth %	-	-88.94	127.92	-90.18
Diluted EPS Before Extra, 1 Yr. Growth %	-	-85.64	-436.44	31.58
Accounts Receivable, 1 Yr. Growth %	-	10.63	17.62	15.67
Inventory, 1 Yr. Growth %	-	22.35	8.52	5.29
Net Property, Plant and Equip., 1 Yr. Growth %	-	6.33	-7.42	-6.27
Total Assets, 1 Yr. Growth %	-	16.39	7.26	2.37
Tangible Book Value, 1 Yr. Growth %	-	-31.16	113.22	-7.94
Common Equity, 1 Yr. Growth %	-	4.26	-9.06	-7.85
Cash From Operations, 1 Yr. Growth %	-	-3.38	-31.03	-17.79
Capital Expenditures, 1 Yr. Growth %	-	-14.25	0.36	-5.11
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-1.51K	-24.8
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-701.16	-42.46
Dividend Per Share, 1 Yr. Growth %	-	0	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	9.42	13.62
Gross Profit, 2 Yr. CAGR %	-	-	11.69	16.59
EBITDA, 2 Yr. CAGR %	-	-	-12.09	130.31
EBITA, 2 Yr. CAGR %	-	-	-17.77	252.56
EBIT, 2 Yr. CAGR %	-	-	-20.8	110.67
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	-31.02	101.95
Net Income, 2 Yr. CAGR %	-	-	-30.74	109.74
Normalized Net Income, 2 Yr. CAGR %	-	-	-48.23	-57.13
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-30.5	110.4
Accounts Receivable, 2 Yr. CAGR %	-	-	14.07	16.64
Inventory, 2 Yr. CAGR %	-	-	15.22	6.89
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-0.78	-6.85
Total Assets, 2 Yr. CAGR %	-	-	11.73	4.79
Tangible Book Value, 2 Yr. CAGR %	-	-	-35.79	40.11
Common Equity, 2 Yr. CAGR %	-	-	-2.63	-8.46
Cash From Operations, 2 Yr. CAGR %	-	-	-18.37	-24.7
Capital Expenditures, 2 Yr. CAGR %	-	-	-7.23	-2.41
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	261.47
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	111.03
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	9.47
Gross Profit, 3 Yr. CAGR %	-	-	-	11
EBITDA, 3 Yr. CAGR %	-	-	-	-8.65
EBITA, 3 Yr. CAGR %	-	-	-	-12.9
EBIT, 3 Yr. CAGR %	-	-	-	-14.17
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	-15.61
Net Income, 3 Yr. CAGR %	-	-	-	-14.32
Normalized Net Income, 3 Yr. CAGR %	-	-	-	-72.15
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-14.02
Accounts Receivable, 3 Yr. CAGR %	-	-	-	14.6
Inventory, 3 Yr. CAGR %	-	-	-	11.81
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	-2.65
Total Assets, 3 Yr. CAGR %	-	-	-	8.52
Tangible Book Value, 3 Yr. CAGR %	-	-	-	-27.59
Common Equity, 3 Yr. CAGR %	-	-	-	-4.4
Cash From Operations, 3 Yr. CAGR %	-	-	-	-18.17
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-6.53